Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Therapy for Secondary Lymphedema
NCT04360889Phase 4Completed
- Sponsor
- Ryazan State Medical University
- Start
- Sep 2019
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of tocopherol, micronized purified flavonoid fraction in lymphedema, sponsored by Ryazan State Medical University. Started Sep 2019; status: completed.
02
Drugs
tocopherolmicronized purified flavonoid fraction
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT04360889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04360889.